Kinnate Biopharma (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- December 19, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $74,500,000
Company Info
- Founders
- Stephen Kaldor, Ph.D.
- Company Description
- Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
- Market
- Precision Oncology
- Location
- San Diego, CA, USA
- Coinvestors
- Eshelman Ventures, Foresite Capital, Nextech Invest, OrbiMed Advisors, Vida Ventures